Skin n Skin Co. Ltd (KQ:159910) — Stock Price
Skin n Skin Co. Ltd (KQ:159910) is currently trading at ₩3340.00 KRW, up 4.38% today. Over the past 52 weeks, shares have ranged between ₩496.00 and ₩3905.00. This page tracks Skin n Skin Co. Ltd's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Skin n Skin Co. Ltd worth.
Skin n Skin Co. Ltd (159910) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Skin n Skin Co. Ltd's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Skin n Skin Co. Ltd Income Statement — Revenue, Profit & Earnings by Year
Skin n Skin Co. Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ₩9.92 Billion | ₩14.52 Billion | ₩13.47 Billion | ₩13.26 Billion | ₩27.61 Billion |
| Cost of Revenue | ₩8.77 Billion | ₩9.44 Billion | ₩10.62 Billion | ₩12.26 Billion | ₩21.04 Billion |
| Gross Profit | ₩1.16 Billion | ₩5.08 Billion | ₩2.85 Billion | ₩1.00 Billion | ₩6.57 Billion |
| Research & Development | ₩147.89 Million | ₩343.42 Million | ₩292.44 Million | ₩252.57 Million | ₩239.54 Million |
| SG&A | ₩1.67 Billion | ₩10.68 Billion | ₩8.86 Billion | ₩7.33 Billion | ₩5.61 Billion |
| Total Operating Expenses | ₩13.88 Billion | ₩20.61 Billion | ₩19.52 Billion | ₩28.09 Billion | ₩25.46 Billion |
| Operating Income | ₩-3.96 Billion | ₩-6.61 Billion | ₩-8.21 Billion | ₩-6.32 Billion | ₩958.61 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | ₩1.91 Billion |
| Interest Expense | ₩980.03 Million | ₩364.72 Million | ₩169.63 Million | ₩124.51 Million | ₩87.08 Million |
| Income Before Tax | ₩-3.81 Billion | ₩-5.59 Billion | ₩-6.02 Billion | ₩-8.33 Billion | ₩1.68 Billion |
| Income Tax Expense | — | — | — | — | — |
| Net Income | ₩-5.68 Billion | ₩-6.11 Billion | ₩-9.44 Billion | ₩-10.04 Billion | ₩1.21 Billion |
Skin n Skin Co. Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Skin n Skin Co. Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ₩36.77 Billion | ₩23.86 Billion | ₩27.25 Billion | ₩35.33 Billion | ₩44.70 Billion |
| Total Current Assets | ₩24.54 Billion | ₩14.48 Billion | ₩12.54 Billion | ₩24.09 Billion | ₩34.72 Billion |
| Cash & Equivalents | — | ₩4.28 Billion | ₩6.66 Billion | ₩14.45 Billion | ₩27.70 Billion |
| Short-term Investments | ₩1.95 Billion | ₩370.00 | ₩27.77 Million | ₩44.04 Million | ₩92.27 Million |
| Net Receivables | ₩873.73 Million | ₩1.51 Billion | ₩2.08 Billion | ₩5.85 Billion | ₩4.22 Billion |
| Inventory | ₩858.76 Million | ₩2.04 Billion | ₩2.62 Billion | ₩2.66 Billion | ₩1.90 Billion |
| Property, Plant & Equipment | — | ₩6.35 Billion | ₩6.55 Billion | ₩5.26 Billion | ₩5.64 Billion |
| Goodwill | ₩0.00 | ₩0.00 | ₩0.00 | ₩947.27 Million | ₩2.90 Billion |
| Total Liabilities | ₩17.07 Billion | ₩10.95 Billion | ₩9.23 Billion | ₩7.87 Billion | ₩7.08 Billion |
| Total Current Liabilities | ₩16.81 Billion | ₩8.98 Billion | ₩6.88 Billion | ₩7.34 Billion | ₩6.79 Billion |
| Long-term Debt | — | ₩0.00 | ₩0.00 | ₩0.00 | ₩323.13 Million |
| Net Debt | ₩592.37 Million | ₩793.16 Million | — | — | — |
| Total Stockholder Equity | ₩19.70 Billion | ₩12.91 Billion | ₩18.03 Billion | ₩27.46 Billion | ₩37.62 Billion |
| Retained Earnings | ₩-87.45 Billion | ₩-81.78 Billion | ₩-75.66 Billion | ₩-96.64 Billion | ₩-86.59 Billion |
Skin n Skin Co. Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Skin n Skin Co. Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩-4.74 Billion | ₩-6.86 Billion | ₩-5.13 Billion | ₩-5.72 Billion | ₩-1.41 Billion |
| Capital Expenditures | ₩825.00 Million | ₩396.12 Million | ₩650.53 Million | ₩410.69 Million | ₩303.04 Million |
| Free Cash Flow | ₩-5.56 Billion | ₩-7.26 Billion | ₩-5.78 Billion | ₩-6.18 Billion | ₩-1.73 Billion |
| Investing Cash Flow | — | ₩859.17 Million | ₩-2.09 Billion | ₩-7.09 Billion | ₩1.96 Billion |
| Financing Cash Flow | — | ₩3.61 Billion | ₩-550.85 Million | ₩-417.19 Million | ₩21.04 Billion |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | ₩520.57 Million | ₩590.80 Million | ₩530.56 Million | ₩1.44 Billion | ₩876.82 Million |
| Change in Cash | ₩5.17 Billion | ₩-2.39 Billion | ₩-7.78 Billion | ₩-13.25 Billion | ₩21.60 Billion |
Skin n Skin Co. Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Skin n Skin Co. Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 68.18 | — | — |
| Dec 31, 2025 | -319.42 | — | — |
| Sep 30, 2025 | -222.31 | — | — |
| Jun 30, 2025 | 4.57 | — | — |
| Mar 31, 2025 | -158.87 | — | — |
| Dec 31, 2024 | -163.97 | — | — |
| Sep 30, 2024 | -260.00 | — | — |
| Jun 30, 2024 | -179.16 | — | — |